Jasper Therapeutics Statistics

Total Valuation

JSPR has a market cap or net worth of $90.28 million. The enterprise value is $44.07 million.

Market Cap	90.28M
Enterprise Value	44.07M

Important Dates

The last earnings date was Monday, May 12, 2025, after market close.

Earnings Date	May 12, 2025
Ex-Dividend Date	n/a

Share Statistics

JSPR has 15.02 million shares outstanding. The number of shares has increased by 29.64% in one year.

Current Share Class	15.02M
Shares Outstanding	15.02M
Shares Change (YoY)	+29.64%
Shares Change (QoQ)	+0.09%
Owned by Insiders (%)	1.27%
Owned by Institutions (%)	55.97%
Float	9.91M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	2.14
P/TBV Ratio	2.14
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.31, with a Debt / Equity ratio of 0.06.

Current Ratio	4.31
Quick Ratio	3.96
Debt / Equity	0.06
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -101.34% and return on invested capital (ROIC) is -64.57%.

Return on Equity (ROE)	-101.34%
Return on Assets (ROA)	-56.50%
Return on Invested Capital (ROIC)	-64.57%
Return on Capital Employed (ROCE)	-183.30%
Revenue Per Employee	n/a
Profits Per Employee	-$1.23M
Employee Count	64
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -77.08% in the last 52 weeks. The beta is 2.72, so JSPR's price volatility has been higher than the market average.

Beta (5Y)	2.72
52-Week Price Change	-77.08%
50-Day Moving Average	4.72
200-Day Moving Average	12.73
Relative Strength Index (RSI)	65.36
Average Volume (20 Days)	217,761

Short Selling Information

The latest short interest is 1.74 million, so 11.61% of the outstanding shares have been sold short.

Short Interest	1.74M
Short Previous Month	1.73M
Short % of Shares Out	11.61%
Short % of Float	17.60%
Short Ratio (days to cover)	11.22

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-82.97M
Pretax Income	-63.93M
Net Income	-78.78M
EBITDA	-81.61M
EBIT	-82.97M
Earnings Per Share (EPS)	-$5.25

Full Income Statement

Balance Sheet

The company has $48.80 million in cash and $2.59 million in debt, giving a net cash position of $46.21 million or $3.08 per share.

Cash & Cash Equivalents	48.80M
Total Debt	2.59M
Net Cash	46.21M
Net Cash Per Share	$3.08
Equity (Book Value)	42.24M
Book Value Per Share	2.81
Working Capital	40.84M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$69.71 million and capital expenditures -$527,000, giving a free cash flow of -$70.24 million.

Operating Cash Flow	-69.71M
Capital Expenditures	-527,000
Free Cash Flow	-70.24M
FCF Per Share	-$4.68

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

JSPR does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-29.64%
Shareholder Yield	-29.64%
Earnings Yield	-87.26%
FCF Yield	-77.79%

Analyst Forecast

The average price target for JSPR is $62.22, which is 935.28% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$62.22
Price Target Difference	935.28%
Analyst Consensus	Strong Buy
Analyst Count	11
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-15.95%

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on January 4, 2024. It was a reverse split with a ratio of 0.1:1.

Last Split Date	Jan 4, 2024
Split Type	Reverse
Split Ratio	0.1:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	1